J Hempel Services LLC: Premier Roofing Replacement Contractor in Lindstrom, MN

Lindstrom, MN – J Hempel Services LLC, a leading general contractor in Lindstrom, MN, specializes in delivering top-tier roofing replacement services. With a focus on quality craftsmanship and customer satisfaction, the company offers a comprehensive approach to roof replacement, ensuring that each project meets the unique needs of homeowners. The roofing replacement process at J […]

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XPEL, Inc. (XPEL) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XPEL, Inc. ("XPEL" or "the Company") (NASDAQ:XPEL). Investors who purchased XPEL securities prior to November 8, 2023, and continue to hold to the present, are encouraged to obtain additional information

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sprout Social, Inc. (SPT) and Encourages Stockholders to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprout Social, Inc. ("Sprout" or "the Company") (NASDAQ:SPT). Investors who purchased Sprout securities prior to November 3, 2021, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lamb Weston Holdings, Inc. (LW) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lamb Weston Holdings, Inc. ("Lamb Weston" or "the Company") (NYSE:LW). Investors who purchased Lamb Weston securities prior to July 25, 2023, and continue to hold to the present, are

Bronstein, Gewirtz & Grossman, LLC Is Investigating Direct Digital Holdings Inc. (DRCT) And Encourages Stockholders to Connect

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Direct Digital Holdings Inc. ("Direct Digital" or "the Company") (NASDAQ:DRCT). Investors who purchased Direct Digital securities prior to April 17, 2023, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the Company") (NASDAQ:AKRO). Investors who purchased Akero securities prior to September 13, 2022, and continue to hold to the present, are encouraged to obtain

Scroll to Top